CRVS

Corvus Pharmaceuticals Inc

May 15 • 04:00PM ET

12.31

-1.34 -9.85 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: RCUS NRIX SNDX IOVA RLAY

| Held by: VTI XBI IWM VXF IWO IBB VTWO VHT LFSC IWC

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.53	Insider Own	23.76%	Shs Outstand	84.09M	Perf Week	-20.84%
Market Cap	1.04B	Forward P/E	-	EPS next Y	-0.85	Insider Trans	0.00%	Shs Float	64.11M	Perf Month	-18.15%
Enterprise Value	799.27M	PEG	-	EPS next Q	-0.16	Inst Own	41.04%	Short Float	28.68%	Perf Quarter	-34.03%
Income	-44.17M	P/S	-	EPS this Y	-258.33%	Inst Trans	7.45%	Short Ratio	13.99	Perf Half Y	50.49%
Sales	0.00M	P/B	4.30	EPS next Y	-25.46%	ROA	-28.26%	Short Interest	18.39M	Perf YTD	59.87%
Book/sh	2.86	P/C	4.37	EPS next 5Y	-	ROE	-30.46%	52W High	26.95 -54.32%	Perf Year	243.85%
Cash/sh	2.81	P/FCF	-	EPS past 3/5Y	15.40% -21.44%	ROIC	-18.32%	52W Low	3.38 264.20%	Perf 3Y	373.46%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	9.13% 8.13%	Perf 5Y	392.40%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	17.91%	Oper. Margin	-	ATR (14)	1.21	Perf 10Y	15.48%
Dividend Ex-Date	-	Quick Ratio	19.81	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	34.19	Recom	1.14
Dividend Gr. 3/5Y	- -	Current Ratio	19.81	EPS Q/Q	-15.05%	SMA20	-20.62%	Beta	0.88	Target Price	33.33
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	-18.79%	Rel Volume	2.65	Prev Close	13.65
Employees	37	LT Debt/Eq	0.00	Earnings	May 07 AMC	SMA200	11.55%	Avg Volume	1.31M	Price	12.31
IPO	Mar 23, 2016	Option/Short	Yes / Yes	EPS/Sales Surpr.	-5.34% -	Trades		Volume	3,481,897	Change	-9.85%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)